Human Peridontal Ligament Fibroblasts (HPLF)

Cat.No.: CSC-7738W

Species: Human

Source: Periodontal Ligament; Periodontium

Cell Type: Fibroblast

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-7738W
Description
Human Peridontal Ligament Fibroblasts(HPLF) from Creative Bioarray are isolated from human periodontal tissue. HPDLF are cryopreserved at passage one and delivered frozen. Each vial contains >5 x 10^5 cells in 1 ml volume. HPDLF are characterized by their spindle morphology and immunofluorescent method with antibody to fibronectin. HPDLF are negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast and fungi. HPDLF are guaranteed to further expand for 15 population doublings at the condition provided by Creative Bioarray.
Species
Human
Source
Periodontal Ligament; Periodontium
Cell Type
Fibroblast
Disease
Normal
Storage and Shipping
Directly and immediately transfer cells from dry ice to liquid nitrogen upon receiving and keep the cells in liquid nitrogen until cell culture needed for experiments.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Human Periodontal Ligament Fibroblasts (HPDLFs) are the principal cellular constituents of the periodontal ligament (PDL), a specialized connective tissue that anchors the tooth root to the alveolar bone. These cells are not mere passive structural components but are highly dynamic and multifunctional. They originate from the dental follicle during tooth development and are uniquely positioned at the interface between two mineralized tissues-cementum and bone. Their primary role is to synthesize, maintain, and remodel the complex extracellular matrix (ECM) of the PDL, which is rich in collagens (notably type I and III), fibronectin, and proteoglycans. This ECM provides the unique biomechanical properties-a combination of toughness and shock absorption-essential for tooth function. Crucially, HPDLFs possess intrinsic osteogenic and cementogenic potential, playing a central role in the continuous remodeling of the periodontal attachment apparatus and in the healing responses following injury or disease.

The primary advantages of HPDLFs in research stem from their unique biological position and functional plasticity, making them indispensable for oral regenerative medicine and biomechanics.

FGF-2+TGF-β3 Regulate Human Gingival and Periodontal Ligament Fibroblast Wound Healing Phenotype

Growth factor therapies for periodontal regeneration have gained traction, but quantification of their effects on multiple different fibroblast populations that are required for repair has been poorly investigated.

In this study, we examined the effects of TGF-β1, TGF-β3, FGF-2, and FGF-9 on human gingival fibroblasts (hGF) and human periodontal ligament cells (hPDL), as well as the combined effects of TGF-β3 and FGF-2. We show that FGF-2 enhances cell migration while TGF-β1 and TGF-β3 promotes matrix production, and TGF-β1 promotes fibroblast to myofibroblast transition. Interestingly, the combination of TGF-β3 and FGF-2, acting through both p-SMAD3 and p-ERK pathways, mitigates the inhibitory effects of TGF-β3 on migration in hPDL cells, suggesting synergistic and complimentary effects of FGF-2 and TGF-β3. Additionally, fibronectin production in hGF increased when treated with the combined TGF-β3+FGF-2 compared to FGF-2 alone, indicating that the effects of TGF-β3 in promoting extracellular matrix production are still active in the combined treatment condition. Finally, our study highlights that FGF-9 did not influence migration, α-SMA expression, or extracellular matrix production in either cell type, emphasizing the unique roles of specific growth factors in cellular responses.

FGF-2 enhanced migration.

Fig. 1. FGF-2 enhances the migration of hPDL and hGF (Guo, Chengyu, Amin S. Rizkalla, and Douglas W. Hamilton. 2025).

The response of hGFs and hPDL cells to combination treatments of TGF-β3+FGF-2.

Fig. 2. TGF-β3+FGF-2 co-treatment does not impede cell migration (Guo, Chengyu, Amin S. Rizkalla, and Douglas W. Hamilton. 2025).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products